Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients

Overview of attention for article published in Journal of Neurology, February 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 55 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 16,505 followers.

New NNT→Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients. https://t.co/ju5phoj618

08 Sep 2018

Reply Repost Favourite

RT @GavinGiovannoni: Why can't EU MSologists offer their patients with MS fingolimod first-line? This study confirms the effectiveness of f…

15 Feb 2018

Reply Repost Favourite

RT @GavinGiovannoni: Why can't EU MSologists offer their patients with MS fingolimod first-line? This study confirms the effectiveness of f…

15 Feb 2018

Reply Repost Favourite

Why can't EU MSologists offer their patients with MS fingolimod first-line? This study confirms the effectiveness of fingolimod in a real-world setting; most patients were NEDA at 2-years. Will Novartis help us get fingo 1st-line? #ClinicSpeak https://t.co

14 Feb 2018

Reply Repost Favourite

Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients. - PubMed - NCBI https://t.co/tqTbaNIwLE

14 Feb 2018

Reply Repost Favourite

New NNT→Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients. https://t.co/ju5phoj618

13 Feb 2018

Reply Repost Favourite